Rankings
▼
Calendar
BHVN Q4 2024 Earnings — Biohaven Ltd. Revenue & Financial Results | Market Cap Arena
BHVN
Biohaven Ltd.
$1B
Q4 2024 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
Gross Profit
$0
Operating Income
-$190M
Net Income
-$187M
EPS (Diluted)
$-1.85
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$171M
Free Cash Flow
-$171M
Stock-Based Comp.
$13M
Balance Sheet
Total Assets
$615M
Total Liabilities
$192M
Stockholders' Equity
$423M
Cash & Equivalents
$99M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
$0
-$948,000
+100.0%
Operating Income
-$190M
-$154M
-23.6%
Net Income
-$187M
-$145M
-29.1%
← FY 2024
All Quarters
Q1 2025 →